KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) EPS (Basic) (2016 - 2026)

Medtronic (MDT) has disclosed EPS (Basic) for 13 consecutive years, with $0.89 as the latest value for Q1 2026.

  • Quarterly EPS (Basic) fell 11.88% to $0.89 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.6 through Jan 2026, up 8.76% year-over-year, with the annual reading at $3.63 for FY2025, 31.05% up from the prior year.
  • EPS (Basic) hit $0.89 in Q1 2026 for Medtronic, down from $1.07 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $1.11 in Q2 2022 to a low of $0.32 in Q4 2022.
  • Historically, EPS (Basic) has averaged $0.84 across 5 years, with a median of $0.89 in 2026.
  • Biggest five-year swings in EPS (Basic): crashed 67.01% in 2022 and later surged 112.5% in 2023.
  • Year by year, EPS (Basic) stood at $0.32 in 2022, then soared by 112.5% to $0.68 in 2023, then skyrocketed by 45.59% to $0.99 in 2024, then grew by 8.08% to $1.07 in 2025, then decreased by 16.82% to $0.89 in 2026.
  • Business Quant data shows EPS (Basic) for MDT at $0.89 in Q1 2026, $1.07 in Q4 2025, and $0.81 in Q3 2025.